AU2015228649A1 - Method for preparing human plasma proteins - Google Patents

Method for preparing human plasma proteins Download PDF

Info

Publication number
AU2015228649A1
AU2015228649A1 AU2015228649A AU2015228649A AU2015228649A1 AU 2015228649 A1 AU2015228649 A1 AU 2015228649A1 AU 2015228649 A AU2015228649 A AU 2015228649A AU 2015228649 A AU2015228649 A AU 2015228649A AU 2015228649 A1 AU2015228649 A1 AU 2015228649A1
Authority
AU
Australia
Prior art keywords
chromatography
plasma
multicolumn
affinity
concentrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2015228649A
Other languages
English (en)
Inventor
Damien BATAILLE
Abdessatar Chtourou
Patrick Santambien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LFB SA
Original Assignee
LFB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51210517&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2015228649(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LFB SA filed Critical LFB SA
Publication of AU2015228649A1 publication Critical patent/AU2015228649A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2015228649A 2014-03-11 2015-03-10 Method for preparing human plasma proteins Abandoned AU2015228649A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1451997 2014-03-11
FR1451997A FR3018450B1 (fr) 2014-03-11 2014-03-11 Procede de preparation de proteines plasmatiques humaines
PCT/FR2015/050598 WO2015136217A1 (fr) 2014-03-11 2015-03-10 Procédé de préparation de protéines plasmatiques humaines

Publications (1)

Publication Number Publication Date
AU2015228649A1 true AU2015228649A1 (en) 2016-09-15

Family

ID=51210517

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015228649A Abandoned AU2015228649A1 (en) 2014-03-11 2015-03-10 Method for preparing human plasma proteins

Country Status (13)

Country Link
US (1) US20170073396A1 (enExample)
EP (1) EP3116527B1 (enExample)
JP (1) JP2017508759A (enExample)
KR (1) KR20160130495A (enExample)
CN (1) CN106103473A (enExample)
AU (1) AU2015228649A1 (enExample)
CA (1) CA2942203A1 (enExample)
ES (1) ES2759259T3 (enExample)
FR (1) FR3018450B1 (enExample)
IL (1) IL247508A0 (enExample)
MX (1) MX2016011641A (enExample)
TW (1) TW201620925A (enExample)
WO (1) WO2015136217A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3481415B1 (fr) 2016-07-06 2023-09-06 Laboratoire Français du Fractionnement et des Biotechnologies Fibrinogène liquide stable

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3018450B1 (fr) 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines
WO2017066683A1 (en) * 2015-10-15 2017-04-20 Plasma Technologies, Llc Methods for extracting proteins from blood plasma
WO2017176735A1 (en) * 2016-04-05 2017-10-12 Haemonetics Corporation Methods and devices for the enrichment of immunoglobulin from blood
FR3053592B1 (fr) * 2016-07-06 2020-05-29 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Fibrinogene liquide stable
EP3275897A1 (en) 2016-07-27 2018-01-31 Biotest AG Process for preparing immunoglobulin compositions
EP3491136A1 (en) 2016-07-28 2019-06-05 Laboratoire Francais du Fractionnement et des Biotechnologies Societe Anonyme Anti- immunoglobulin g aptamers and uses thereof
WO2018117143A1 (ja) * 2016-12-22 2018-06-28 一般財団法人化学及血清療法研究所 血液凝固第ｖｉｉ因子の高収率回収のためのクロマトグラフィー法
FR3061020B1 (fr) 2016-12-22 2019-05-17 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Composition de fibrinogene humain
WO2018165766A1 (en) * 2017-03-16 2018-09-20 Therapure Biopharma Inc. Method for purification of albumin
CN107033237B (zh) * 2017-05-11 2021-07-20 深圳市卫光生物制品股份有限公司 一种人血浆载脂蛋白a-i的分离纯化方法
CN107216384A (zh) * 2017-05-11 2017-09-29 深圳市卫光生物制品股份有限公司 一种人血浆转铁蛋白分离纯化的方法
CN107827974B (zh) * 2017-11-10 2021-01-01 中国科学院过程工程研究所 一种人纤维蛋白原的制备方法
CN108101981B (zh) * 2018-01-15 2019-06-04 四川远大蜀阳药业有限责任公司 一种静注免疫球蛋白的生产工艺
FR3081328B1 (fr) * 2018-05-24 2021-01-01 Lab Francais Du Fractionnement Composition d'immunoglobulines humaines concentrees
FR3090321B1 (fr) * 2018-12-21 2023-07-14 Lab Francais Du Fractionnement Procédé de filtration du fibrinogène
EP3962924A1 (en) * 2019-05-03 2022-03-09 Genentech, Inc. Methods of reducing the enzymatic hydrolysis activity rate in a composition obtained from a purification platform
CN110314414B (zh) * 2019-07-23 2021-10-19 宝锐生物科技泰州有限公司 凝血因子xiii的分离纯化方法及其应用
US11833279B2 (en) * 2021-06-11 2023-12-05 Astaria Global, LLC System and method for isolating alpha 2M molecules
CN113754757B (zh) * 2021-07-01 2024-06-14 华兰生物工程股份有限公司 一种人纤维蛋白原的制备方法
EP4377361A1 (en) * 2021-07-29 2024-06-05 CSL Behring AG Method of purifying immunoglobulin g and uses thereof
CN113563457B (zh) * 2021-08-20 2023-02-24 华兰生物工程股份有限公司 一种同时制备人纤维蛋白原、凝血因子ⅷ和纤溶酶原的方法
CN114835801B (zh) * 2022-06-20 2023-09-22 华润博雅生物制药集团股份有限公司 一种c1酯酶抑制剂及其制备方法
CN117069836B (zh) * 2023-09-22 2024-08-27 武汉中生毓晋生物医药有限责任公司 一种抗人t细胞兔免疫球蛋白的制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1055825A (fr) 1951-02-20 1954-02-22 Perfectionnement aux montures de lunettes optiques, solaires et faces supplémentaires solaires
BE517346A (enExample) 1952-04-21
CN1072419A (zh) * 1991-11-20 1993-05-26 中国科学院大连化学物理研究所 径向色谱柱用离子交换介质的合成
FR2706466B1 (fr) 1993-06-14 1995-08-25 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
EP0764658B1 (de) * 1995-09-22 2002-01-02 ZLB Bioplasma AG Verfahren zur Gewinnung von Immunglobulinen aus Fraktionen, die bei der Fraktionierung von menschlichem Blutplasma entstehen
PL196770B1 (pl) * 1998-06-09 2008-01-31 Statens Seruminstitut Sposób oczyszczania immunoglobuliny, produkt immunoglobuliny i jego zastosowanie
ES2421736T3 (es) * 1998-06-09 2013-09-05 Csl Behring Ag Procedimiento para la preparación de inmunoglobulinas para administración intravenosa y otros productos inmunoglobulínicos
DE19858892A1 (de) * 1998-12-19 2000-06-21 Merck Patent Gmbh Kontinuierliches Verfahren zur Trennung von Stoffen nach Molekülgröße
SE0001128D0 (sv) * 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
FR2824568B1 (fr) * 2001-05-11 2004-04-09 Lab Francais Du Fractionnement Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique
PL1786273T3 (pl) * 2004-08-20 2019-05-31 Prometic Biosciences Ltd Schematy sekwencyjnego izolowania i oczyszczania białek sposobem chromatografii powinowactwa
EP1775001A1 (en) * 2005-10-13 2007-04-18 Xendo Holding B.V. Device for chromatographic separations
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives
WO2007144476A1 (fr) * 2006-06-16 2007-12-21 Groupe Novasep Procede de separation sequence multicolonnes
JP5571552B2 (ja) * 2007-06-15 2014-08-13 ジーイー・ヘルスケア・バイオ−サイエンシズ・アーベー クロマトグラフィー法
FR2929533B1 (fr) * 2008-04-03 2010-04-30 Novasep Procede de separation multicolonnes a gradient.
FR2939667B1 (fr) * 2008-12-17 2012-01-27 Fractionnement Et Des Biotechonologies Lab Franc Composition d'immunoglobine g comme medicament pour le traitement de l'ictere neonatal par incompatibilite foetomaternelle dans le systeme abo
FR2942233B1 (fr) * 2009-02-19 2015-03-13 Lfb Biotechnologies Moyens pour la purification d'une proteine du plasma sanguin, et procedes pour sa mise en oeuvre
FR2970003B1 (fr) 2010-12-30 2013-01-25 Lfb Biotechnologies Procede d'immobilisation d'acides nucleiques
FR2977893B1 (fr) * 2011-07-11 2015-02-20 Lab Francais Du Fractionnement Procede de preparation d'un concentre d'immunoglobulines polyvalentes
EP2656892A1 (en) 2012-04-23 2013-10-30 Merck Patent GmbH Chromatography method
FR3018450B1 (fr) 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3481415B1 (fr) 2016-07-06 2023-09-06 Laboratoire Français du Fractionnement et des Biotechnologies Fibrinogène liquide stable

Also Published As

Publication number Publication date
IL247508A0 (en) 2016-11-30
KR20160130495A (ko) 2016-11-11
MX2016011641A (es) 2016-10-31
FR3018450B1 (fr) 2016-04-15
EP3116527B1 (fr) 2019-09-04
CN106103473A (zh) 2016-11-09
ES2759259T3 (es) 2020-05-08
FR3018450A1 (fr) 2015-09-18
JP2017508759A (ja) 2017-03-30
TW201620925A (zh) 2016-06-16
US20170073396A1 (en) 2017-03-16
WO2015136217A1 (fr) 2015-09-17
CA2942203A1 (fr) 2015-09-17
EP3116527A1 (fr) 2017-01-18

Similar Documents

Publication Publication Date Title
US20170073396A1 (en) Method for preparing human plasma proteins
CN106459142B (zh) 使用辛酸纯化蛋白质的方法
CN102712673B (zh) 用于纯化含fc的蛋白的色谱方法
US20130178608A1 (en) Protein purification by ion exchange
US20110237781A1 (en) Method of preparing alpha-1 proteinase inhibitor
US9663553B2 (en) Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma
KR20180101583A (ko) 혈액 기반 물질로부터 단백질을 추출하기 위한 방법(methods for extracting proteins from a blood-based material)
Lihme et al. A novel core fractionation process of human plasma by expanded bed adsorption chromatography
US9403899B2 (en) Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition
US20130116413A1 (en) Purification of proteins
JP2016199586A (ja) 熱処理を通じてＩｇＧ組成物を得るための方法
JP2024527980A (ja) 免疫グロブリンｇを精製する方法およびその使用
Hofbauer et al. Affinity chromatography for purification of IgG from human plasma
KR20070091098A (ko) 단백질 분리 방법
Curling Integrating new technology into blood plasma fractionation
CN117769570A (zh) 纯化免疫球蛋白g的方法及其用途
WO2025008781A1 (en) Method of purification
AU2015268579A1 (en) Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition
HK1199267B (en) Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application